五月婷网站,av先锋丝袜天堂,看全色黄大色大片免费久久怂,中国人免费观看的视频在线,亚洲国产日本,毛片96视频免费观看

您好, 歡迎來到化工儀器網

| 注冊| 產品展廳| 收藏該商鋪

400-609-0003

products

目錄:普邁精醫(yī)科技(北京)有限公司>>細胞培養(yǎng)產品>>類器官/干細胞培養(yǎng)/細胞培養(yǎng)>> 類器官Dexamethasone (DHAP)

類器官Dexamethasone (DHAP)
  • 類器官Dexamethasone (DHAP)
  • 類器官Dexamethasone (DHAP)
參考價 500
訂貨量 ≥1ml
具體成交價以合同協(xié)議為準
500
≥1ml
具體成交價以合同協(xié)議為準
  • 品牌 其他品牌
  • 型號
  • 廠商性質 代理商
  • 所在地 北京市
屬性

供貨周期:現貨

>

更新時間:2024-11-06 17:37:46瀏覽次數:417評價

聯系我們時請說明是化工儀器網上看到的信息,謝謝!

同類優(yōu)質產品

更多產品
供貨周期 現貨
類器官Dexamethasone (DHAP)
類器官(Organoids)是指將成體干細胞或多能干細胞在體外三維培養(yǎng)形成的具有一定空間結構的組織類似物。類器官在組織結構、細胞類型、自我更新能力和功能等方面與來源組織高度一致,從而在發(fā)育生物學、疾病造模、精準醫(yī)學、藥物研發(fā)、基因和細胞療法、感染和免疫以及再生醫(yī)學等生物醫(yī)學的多個領域展現出*的優(yōu)勢。

類器官Dexamethasone (DHAP)類器官(Organoids)是指將成體干細胞或多能干細胞在體外三維培養(yǎng)形成的具有一定空間結構的組織類似物。類器官在組織結構、細胞類型、自我更新能力和功能等方面與來源組織高度一致,從而在發(fā)育生物學、疾病造模、精準醫(yī)學、藥物研發(fā)、基因和細胞療法、感染和免疫以及再生醫(yī)學等生物醫(yī)學的多個領域展現出*的優(yōu)勢。

產品介紹
DESCRIPTION

BackgroundDexamethasone is a glucocorticoid receptor agonist. Dexamethasone also significantly decreases CD11b, CD18, and CD62L expression on neutrophils, and CD11b and CD18 expression on monocytes. Dexamethasone is highly effective in the control of infection. Dexamethasone inhibits production of exosomes containing inflammatory microRNA-155 in lipopolysaccharide-induced macrophage inflammatory responses.
AliasSynonyms,地塞米松,Hexadecadrol,Prednisolone F
M. W t392.46
FormulaC22H29FO5
CAS No50-02-2
StoragePowder-20°C3 years                                                                                                                             
In solvent-80°C     2 years                  
SolubilityDMSO 250 mg/mL(637.01 mM; ultrasonic and warming and heat to 60°C)
Ethanol 8.33 mg/mL(21.23 mM; Need ultrasonic)

H2O< 0.1 mg/mL(insoluble)

 


技術參數BIOLOGICAL ALTIVITY
In Vitro   
Dexamethasone regulates several transcription factors, including activator protein-1, nuclear factor-AT, and nuclear factor-kB, leading to the activation and repression of key genes involved in the inflammatory response[1].
Dexamethasone potently inhibits granulocyte-macrophage colony stimulating factor (GM-CSF) release from A549 cells with EC50 of 2.2 nM. Dexamethasone (EC50=36 nM) induces transcription of the β2-receptor is found to correlate with glucocorticoid receptor (GR) DNA binding and occurred at 10-100 fold higher concentrations than the inhibition of GM-CSF release. Dexamethasone (IC50=0.5 nM) inhibits a 3×κB (NF-κB, IκBα, and I-κBβ), which is associated with inhibition of GM-CSF release[2].
In Vivo  
It has previously been reported that treatment with Dexamethasone at a dose of 2×5 mg/kg efficiently inhibits lipopolysaccharide (LPS)-induced inflammation. In our experimental system, treatment with a single dose of Dexamethasone 10 mg/kg (i.p.) significantly decreases recruitment of granulocytes as well as spontaneous production of oxygen radicals compared with animals expose to LPS and injected with solvent alone (saline). The effects are statistically significant when administered both 1 h before and 1 h after inhalation of LPS. The number of granulocytes in BALF decreased to levels comparable to healthy animals (given an aerosol of water)[3].

類器官Dexamethasone (DHAP)

會員登錄

請輸入賬號

請輸入密碼

=請輸驗證碼

收藏該商鋪

標簽:
保存成功

(空格分隔,最多3個,單個標簽最多10個字符)

常用:

提示

您的留言已提交成功!我們將在第一時間回復您~
在線留言

會員登錄

請輸入賬號

請輸入密碼

=

請輸驗證碼

收藏該商鋪

該信息已收藏!
標簽:
保存成功

(空格分隔,最多3個,單個標簽最多10個字符)

常用:
熱線電話 在線詢價